Riskpilot← Back to searchSign inGet full accessMedproffs Stockholm AB
ABActiveOrg 5591293906Liljeörnsgatan 41 Lgh 1004Other human health activities n.e.c. · NACE 8699Est. 20171 employees
Revenue 2025
SEK 272K
EBITDA margin
79.0%
+501% vs 2024
Equity ratio
47.6%
Financial strength
Net profit 2025
SEK 181K
+438% vs 2024
| Revenue | SEK 272K | — |
| EBITDA | SEK 215K | +501% |
| Net profit | SEK 181K | +438% |
| Total assets | SEK 378K | +722% |
| Equity | SEK 180K | +13957% |
| Employees | 1 | — |
Legal name
Medproffs Stockholm AB
Org number
5591293906
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
16 oktober 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom vård och omsorg, främst genom att tillhandahålla underskötersketjänster direkt till uppdragsgivare. Bolaget kan även bedriva därmed förenlig verksamhet.
Address
Liljeörnsgatan 41 Lgh 1004
Email
bilal.ebrahimi10@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 124 | 251 | 71 | 0 | 272 |
| Staff expenses | — | −82 | −96 | −26 | — |
| EBITDA | 62 | 14 | −49 | −54 | 215 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | 62 | 14 | −49 | −54 | 215 |
| Net financials | — | −0 | −1 | — | — |
| Profit before tax | 62 | 14 | −50 | −54 | 215 |
| Tax | −13 | −3 | — | — | −34 |
| Net profit | 49 | 11 | −50 | −54 | 181 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 93 | 151 | 82 | 46 | 378 |
| Equity | 91 | 102 | 52 | −1 | 180 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 2 | 49 | 30 | 47 | 199 |
| Total debt | 2 | 49 | 30 | 47 | 199 |
EBITDA margin
79.0%
This company
15.8%
Market median
+400% vs market
20212025
Equity ratio
47.6%
This company
38.2%
Market median
+25% vs market
20212025
Return on equity
100.6%
This company
18.4%
Market median
+447% vs market
20212025
Net profit margin
66.5%
This company
8.1%
Market median
+721% vs market
20212025
Asset turnover
0.72×
This company
1.12×
Market median
-36% vs market
20212025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (3) | ||
| Deputy Board Member | 2020 – 2021 | |
| Chairman | 2025 – 2025 | |
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medproffs Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Inés Devivez | Deputy Board Member | 0 companies |
| Bilal Rohullah Ebrahimi | Board of Directors | 0 companies |
| Ozioma Amarachi Egenaonu | Deputy Board Member | 0 companies |
| Shukria Ebrahimi | Chairman | 0 companies |
| Charles Nwanaka Egenaonu | Board of Directors | 0 companies |